NO923763L - Injiserbare formuleringer med forlanget frigjoering, og fremgangsmaate for deres fremstilling - Google Patents

Injiserbare formuleringer med forlanget frigjoering, og fremgangsmaate for deres fremstilling

Info

Publication number
NO923763L
NO923763L NO92923763A NO923763A NO923763L NO 923763 L NO923763 L NO 923763L NO 92923763 A NO92923763 A NO 92923763A NO 923763 A NO923763 A NO 923763A NO 923763 L NO923763 L NO 923763L
Authority
NO
Norway
Prior art keywords
procedure
preparation
injectable forms
required release
release
Prior art date
Application number
NO92923763A
Other languages
English (en)
Norwegian (no)
Other versions
NO923763D0 (no
Inventor
Norman Dale Brooks
Gregory Frank Needham
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/934,017 external-priority patent/US5352662A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO923763D0 publication Critical patent/NO923763D0/no
Publication of NO923763L publication Critical patent/NO923763L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO92923763A 1991-10-01 1992-09-28 Injiserbare formuleringer med forlanget frigjoering, og fremgangsmaate for deres fremstilling NO923763L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76955591A 1991-10-01 1991-10-01
US07/934,017 US5352662A (en) 1991-10-01 1992-08-21 Injectable extended release formulations and methods

Publications (2)

Publication Number Publication Date
NO923763D0 NO923763D0 (no) 1992-09-28
NO923763L true NO923763L (no) 1993-04-02

Family

ID=27118187

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923763A NO923763L (no) 1991-10-01 1992-09-28 Injiserbare formuleringer med forlanget frigjoering, og fremgangsmaate for deres fremstilling

Country Status (13)

Country Link
EP (1) EP0535899A1 (xx)
JP (1) JPH05194273A (xx)
CN (1) CN1071845A (xx)
AU (1) AU652284B2 (xx)
BR (1) BR9203798A (xx)
CA (1) CA2079541A1 (xx)
CZ (1) CZ294992A3 (xx)
FI (1) FI924335A (xx)
HU (1) HUT66070A (xx)
IL (1) IL103275A0 (xx)
MX (1) MX9205508A (xx)
NO (1) NO923763L (xx)
NZ (1) NZ244550A (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07112940A (ja) * 1993-08-26 1995-05-02 Takeda Chem Ind Ltd 徐放性非経口投与製剤およびその製造方法
CA2222567C (en) * 1995-06-07 2002-01-29 Southern Biosystems, Inc. High viscosity liquid controlled biologically active delivery system
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US5817627A (en) * 1996-06-14 1998-10-06 Theratechnologies Inc. Long-acting galenical formulation for GRF peptides
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI1575569T1 (sl) 2002-12-13 2010-12-31 Durect Corp Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
EP2415484B1 (en) 2004-09-17 2014-06-18 Durect Corporation Sustained local anesthetic composition containing SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
CA2706931C (en) 2007-12-06 2015-05-12 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
EP2983468A4 (en) 2013-03-15 2016-09-07 Durect Corp COMPOSITIONS WITH RHEOLOGY MODIFIER TO REDUCE RESOLUTION VARIABILITY
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189673B1 (en) * 1984-12-24 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Stable growth hormone releasing factor preparation
CA1285874C (en) * 1985-08-23 1991-07-09 Thomas Harry Ferguson Injectable sustained release formulation
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use

Also Published As

Publication number Publication date
CZ294992A3 (en) 1993-04-14
CN1071845A (zh) 1993-05-12
CA2079541A1 (en) 1993-04-02
AU2600992A (en) 1993-04-08
HU9203102D0 (en) 1992-12-28
IL103275A0 (en) 1993-02-21
FI924335A (fi) 1993-04-02
FI924335A0 (fi) 1992-09-28
NZ244550A (en) 1994-03-25
EP0535899A1 (en) 1993-04-07
JPH05194273A (ja) 1993-08-03
NO923763D0 (no) 1992-09-28
MX9205508A (es) 1993-07-01
AU652284B2 (en) 1994-08-18
HUT66070A (en) 1994-09-28
BR9203798A (pt) 1993-04-27

Similar Documents

Publication Publication Date Title
NO871243D0 (no) Farmasoeytisk preparat med langvarig frigjoering og fremgangsmaate for dets fremstilling.
DK0699436T4 (da) Præparat med reguleret frigivelse
DK371389D0 (da) Substituerede aminomethyltetraliner og deres heterocycliske analoge, deres fremstilling og anvendelse
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
DK609489D0 (da) Imidazolderivater, deres fremstilling og anvendelse
NO923763L (no) Injiserbare formuleringer med forlanget frigjoering, og fremgangsmaate for deres fremstilling
NO915105D0 (no) Organiske kopolymerer, fremgangsmaate for deres fremstilling og anvendelse
DK348185A (da) Mikrokapsler med kontrolleret frigivelse, deres fremstilling og anvendelse
NO903636L (no) Makrocykliske forbindelser og fremgangsmaate for deres fremstilling.
DK193088A (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
NO900943D0 (no) Kopolymerer, fremgangsmaate for deres fremstilling og anvendelse.
DK530689D0 (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
DK16187D0 (da) Farmaceutisk sammensaetning med langvarig frigoerelse og fremgangsmaade til fremstilling af samme
NO922842L (no) Benzotiazolderivater, fremgangsmaate for deres fremstilling og deres anvendelse som terapeutika
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
DK222488A (da) Glycopeptider med enkephalinase-haemmende virkning,deres fremstilling og anvendelse
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK578789A (da) Pyrrolidin-2-carboxylsyre-derivater med psykotrop virkning, deres fremstilling og anvendelse
NO911047D0 (no) Labdaner og fremgangsmaate for deres fremstilling.
DK469389D0 (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
DK127288A (da) Imidazodiazepin-derivater, deres fremstilling og anvendelse
DK189488D0 (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
NO922992L (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
NO921878D0 (no) Nitrittoksyderte lignosulfonater og fremgangsmaate for deres fremstilling
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.